2021 Symposium Recap
The 9th Annual Symposium on Global Cancer Research was held as a satellite meeting to the Consortium of Universities for Global Health Annual Conference on March 10-11, 2021. The virtual format allowed for diverse participation by over 400 attendees from 70 countries, 29 speakers from 12 countries, and presentation of research conducted in 68 countries.
The two-day program focused on fundamental issues of equity and resilience based on events of 2020 and 2021, including the ongoing COVID-19 pandemic and the global movement for racial equity. Its purpose was to integrate and disseminate current scientific knowledge in global cancer control and to support global scientific collaboration. In addition, 98 accepted scientific abstracts and an editorial were published in a special issue of AACR’s Cancer Epidemiology, Biomarkers & Prevention. Key sessions that took place during the Symposium included:
Day 1 - March 10, 2021 (Link to recording)
- Building Towards Resilience in Cancer Care, Control, and Research Panel focused on building towards resilient health systems and addressing critical gaps and emergent threats to cancer prevention and control in LMICs
- Rapid Fire Oral Abstract Presentations for 10 of the highest scoring accepted scientific abstracts
Day 2 - March 11, 2021 (Link to recording)
- Building Towards Equity Panel focused on translational gaps between science conducted in LMICs and building effective partnerships and robust community engagement
- Rachel Pearline Award Presentations to the 2020 award winner Dr. Frederick Chite Asirwa, Consultant Physician, Medical Oncologist and Hematologist, and CEO of the International Cancer Institute; and the 2021 award winner Dr. Karla Alfaro, MD, MPH, Medical Director of Basic Health International in San Salvador, El Salvador
The Annual Symposium on Global Cancer Research is a signature event which brings together a group of global oncology researchers, clinicians, advocates, policymakers, funders, and students.
Scientific Steering Committee:
Carl E. Allen, MD, PhD
Co-Director, Histiocytosis Program, Co-Director, Lymphoma Program, Director of Research, Global Hematology-Oncology Pediatric Excellence (HOPE), Associate Professor, Department of Pediatrics, Baylor College of Medicine/Texas Children’s Hospital, Houston, TX, USA
Sharmila Anandasabapathy, MD
Professor of Medicine in Gastroenterology, Director, Baylor Global Initiatives, Director, Baylor Global Innovation Center, Baylor College of Medicine, Houston, TX, USA
Ellen Baker, MD
Director, Project ECHO, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Frédéric Biemar, PhD
Director, International Affairs, American Association for Cancer Research, Philadelphia, PA, USA
María Teresa Bourlon, MD, MSc
Representative, Academic Global Oncology Task Force, American Society of Clinical Oncology;
Assistant Professor, Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
Mishka Kohli Cira, MPH
Public Health Advisor, Center for Global Health, US National Cancer Institute, Rockville, MD, USA
Kalina Duncan, DrPH [c], MPH
Branch Chief, Partnerships and Dissemination, Center for Global Health, US National Cancer Institute, Rockville, MD, USA
Linsey Eldridge, MPH
Cancer Research Training Award Fellow, Center for Global Health, US National Cancer Institute, Rockville, MD, USA
Suzanne A.W. Fuqua, PhD
Professor, Breast Center – Fuqua, Co-Associate Director of Education, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA
Elise M. Garton, MS
Presidential Management Fellow, Center for Global Health, US National Cancer Institute, Rockville, MD, USA
Shubhra Ghosh, MD
Project Manager, Global Programs, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Satish Gopal, MD, MPH
Director, Center for Global Health, US National Cancer Institute, Rockville, MD, USA
Rashieda J. Hatcher, PhD
Academic Administrator, Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, USA
Catherine Hidalgo
Program Analyst, Center for Global Health, US National Cancer Institute, Rockville, MD, USA
Cesaltina Ferreira Lorenzoni, MD, PhD
Head, Cancer Control Program, Ministry of Health, Republic of Mozambique, Maputo, Mozambique
Keith Martin, MD, PC
Executive Director, Consortium of Universities for Global Health, Washington, DC, USA
Miriam Mutebi, MD
Breast Surgical Oncologist, Aga Khan University Hospital, Nairobi, Kenya
Dalal Najjar Cobb
Deputy Director, Consortium of Universities for Global Health, Washington, DC, USA
Lisa A. Newman, MD, MPH, FACS, FASCO
Chief, Breast Surgical Oncology Programs, Weill Cornell Medicine - New York Presbyterian Hospital Network, New York, NY, USA
Valerie A. Paz-Soldan, PhD, MPH
Director of Tulane Health Offices for Latin America, Tulane University School of Public Health and Tropical Medicine, Lima, Peru
Paul Pearlman, PhD
Program Director; Lead, Global Health Technology, Center for Global Health, US National Cancer Institute, Rockville, MD, USA
Laura Prakash, MPH
Data Analyst, Frederick National Laboratory for Cancer Research with support to Center for Global Health, US National Cancer Institute, Rockville, MD, USA
Anne F. Rositch, MSPH, PhD
Associate Professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; Sidney Kimmel Comprehensive Cancer Center
Kathleen Schmeler, MD
Professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, University of Texas MD Anderson Cancer Center
Jenna Smith
Events and Memberships Manager, Consortium of Universities for Global Health
Melissa Lopez Varon, MS
Partner Liaison, Project ECHO, University of Texas MD Anderson Cancer Center
The Center for Global Health looks forward to hosting the 2022 Annual Symposium on March 22-24, 2022 to advance opportunities for collaboration and the exchange of knowledge in global cancer control.
